Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives $6.13 Average PT from Brokerages
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) have been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy […]
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) have been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy […]
